Table 2.
Intervention Facilities | Control Facilities | ||||||
---|---|---|---|---|---|---|---|
All clinical fractures | |||||||
Baseline | Follow-up | P | Baseline | Follow-up | P | P* | |
N=900 | N=1062 | N=599 | N=520 | ||||
Bisphosphonate | 43 (4.8%) | 78 (7.3%) | 0.02 | 37 (6.2%) | 23 (4.4%) | 0.23 | 0.02 |
CA and/or Vit. D | 192 (21.3%) | 374 (35.2%) | <0.01 | 213 (35.6%) | 179 (34.4%) | 0.71 | <0.01 |
Major osteoporotic fractures | |||||||
Baseline | Follow-up | Baseline | Follow-up | ||||
N=249 | N=309 | N=163 | N=162 | ||||
Bisphosphonate | 19 (7.6%) | 35 (11.3%) | 0.15 | 14 (8.6%) | 11 (6.8%) | 0.68 | 0.18 |
CA and/or Vit. D | 69 (27.7%) | 132 (42.7%) | <0.01 | 64 (39.3%) | 64 (39.5%) | 1.00 | 0.02 |
P compares treatment rates before and after implementation of the E-consult service within facilities group
P compares treatment rates between intervention and control facilities